Global Fund awards bring total to $2.1bn and supply ARVs to 700,000 people

Commentary: The Global Fund and treatment access in Latin America – a critical view

Commentary: China starts long march against HIV

WHO guidelines for use of ARVs in resource-poor settings

Millions will benefit after GSK and BI license generic manufacturers to produce AZT, lamivudine and nevirapine

Scaling up treatment access risks damaging national health systems, says WHO/UK report

Importance of dietary management in treating lipid disorders: soy diets may offer comparable effect as statins

Human histology and persistence of various injectable filler substances for soft tissue augmentation

Treating oral hairy leukoplakia with high dose valacyclovir

Stem-cell transplants help beat lymphoma

Should treatment be started in all newborns infected with HIV?

Tenofovir levels in children approach adult values

Study suggests paediatric dose of emtricitabine (FTC)

HIV production in children with “undetectable” viral load

Host genetic factors are important in disease progression in children

London study finds sexual and intranasal transmission of HCV

HCV-coinfection is associated with diabetes and CD4 decline

US approves 10-minute HIV test

Rapid HIV tests offer economic advantages and convenience

Use of total lymphocyte count (TLC) for monitoring response to antiretroviral therapy

Controversy surrounds British health plans for visitors to the UK

Doctors warn of death toll from silent epidemic of hepatitis C

WHO guidelines for use of ARVs in resource-poor settings

Conferences and guidelines

Vaccine research

Journal articles available online

Online medical lectures


Newsletters and reports

Volume 5 Number 1/2 February/March 2004 PDF

Post navigation